This text introduces common immunohistochemical markers for pancreatic cells and tumors. Insulin/C‑peptide, glucagon, and NKX6.1 serve as key markers for pancreatic β and α cells, respectively. Pan‑keratin and CD200 help differentiate pancreatic adenocarcinomas and neuroendocrine tumors. Relevant antibodies and their applications are also listed.
The 90 kDa ribosomal S6 kinases (RSK1–4) are a widely expressed family of serine/threonine kinases, featuring two distinct functional kinase domains and a C-terminal docking site for extracellular signal-regulated kinases (ERKs). Key phosphorylation sites, including Ser380, Thr359, Ser363, and Thr573, are critical for RSK activation. RSK1–3 are activated by coordinated phosphorylation mediated by mitogen-activated protein kinases (MAPKs), autophosphorylation, and phosphoinositide-3-OH kinase (PI3K) in response to growth factors, polypeptide hormones, and neurotransmitters. This paper also lists relevant antibodies for RSK detection and provides related research references.
p70 S6 kinase is a mitogen‑activated Ser/Thr protein kinase essential for cell growth and G1 cell cycle progression. It phosphorylates the S6 protein of the 40S ribosomal subunit at key residues (Ser235, Ser236, Ser240, Ser244) and regulates translation of 5′ oligopyrimidine tract mRNAs. In vivo, it phosphorylates eIF4B at the rapamycin‑sensitive Ser422 site; the Ser422Ala mutant of eIF4B exhibits reduced activity in in vitro translation assays. Additionally, phosphorylation of eEF2K by p70 S6 kinase and p90RSK inactivates eEF2K, promoting eEF2 dephosphorylation and facilitating protein translation. This paper summarizes specific antibodies targeting key proteins in this pathway, providing experimental tools for related molecular mechanism studies.
The nucleosome, made up of four core histone proteins (H2A, H2B, H3, and H4), is the primary building block of chromatin. Originally thought to function as a static scaffold for DNA packaging, histones have now been shown to be dynamic proteins, undergoing multiple types of post-translational modifications, including acetylation, phosphorylation, methylation, and ubiquitination .
The p53 tumor suppressor protein is critical for cellular responses to DNA damage, triggering cell cycle arrest, DNA repair, or apoptosis. Its activity is tightly regulated via post‑translational modifications, including phosphorylation (Ser6/9/15/20/33/392) and acetylation (Lys382), which disrupt MDM2‑mediated degradation. Key kinases (ATM/ATR/Chk1/Chk2) and acetyltransferases (p300/CBP) modulate p53 function, while SIRT1 mediates deacetylation. Specific antibodies targeting modified p53 enable detection in research applications.
Organelle localization is a dynamic process regulated by the cytoskeleton and specific signal sequences. Endogenous targeting signals determine protein destinations, while exogenous strategies direct drugs and nanoparticles to organelles for therapy. Accurate subcellular distribution analysis aids therapeutic evaluation.
Nuclear receptors are ligand‑dependent transcription factors regulating reproduction, development and metabolism via post‑translational modifications. Key members include AR, ERα, GR, PPARγ, PR, RARs and RXRs, each mediating distinct biological processes. Relevant antibodies for research are listed.
Tight junctions (zona occludens) form a continuous fluid barrier across epithelium and endothelium, regulating paracellular permeability and maintaining cell polarity by blocking the movement of transmembrane proteins between apical and basolateral cell surfaces. Composed of claudin and occludin transmembrane proteins, tight junctions link to the cytoskeleton via zona occludens proteins ZO-1, ZO-2 and ZO-3. The claudin family determines epithelial barrier properties, while ZO-1 and ZO-2 are essential for tight junction assembly and function; ZO-3 negatively regulates junction formation. Afadin participates in cell movement directionality, and CD2AP contributes to tight junction formation in specialized cells and EGFR endocytosis. This paper also lists relevant antibodies for tight junction protein detection.
cLEF1 and TCF belong to the high mobility group (HMG) DNA‑binding transcription factor family, which includes LEF1, TCF1 (TCF7), TCF3 (TCF7L1), and TCF4 (TCF7L2). LEF1 and TCF1/TCF7 are key regulators of early lymphoid development and act downstream of the Wnt signaling pathway. They bind to Wnt response elements and provide docking sites for β‑catenin; upon Wnt activation, β‑catenin translocates into the nucleus to promote target gene transcription. These proteins are dynamically expressed during development, and aberrant activation of the Wnt pathway is associated with many cancers including colon cancer. Relevant antibodies for detecting these proteins and reference literature are also listed.
